FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101735 [Registered on: 21/01/2026] Trial Registered Prospectively
Last Modified On: 21/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of ayurvedic medicine with and without Panchakarma procedure in the management of Sthaulya w.s.r. to Obesity 
Scientific Title of Study   A comparative clinical study to evaluate the efficacy of Trayushanadi Loha with and without Virechana in the management of Sthaulya w.s.r. to Obesity 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kavita Gupta 
Designation  PG Scholar 
Affiliation  Dayanand Ayurvedic College, Jalandhar 
Address  Department of Panchakarma Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg, Jalandhar, Punjab, India

Jalandhar
PUNJAB
144008
India 
Phone  7888901900  
Fax    
Email  kavitaguptamlt@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Parveen Kumar 
Designation  Professor and HOD of Panchakarma 
Affiliation  Dayanand Ayurvedic College, Jalandhar 
Address  Department of Panchakarma Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg, Jalandhar, Punjab, India

Jalandhar
PUNJAB
144008
India 
Phone  7589303536  
Fax    
Email  drparv1@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kavita Gupta 
Designation  PG Scholar 
Affiliation  Dayanand Ayurvedic College, Jalandhar 
Address  Department of Panchakarma Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg, Jalandhar, Punjab, India

Jalandhar
PUNJAB
144008
India 
Phone  7888901900  
Fax    
Email  kavitaguptamlt@gmail.com  
 
Source of Monetary or Material Support  
Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg, Jalandhar, Punjab, 144008, India 
 
Primary Sponsor  
Name  Dayanand Ayurvedic College and Hospital Jalandhar 
Address  Department of Panchakarma, Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg, opp Burlton Park, Jalandhar, Punjab, 144008, India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kavita Gupta  Dayanand Ayurvedic Hospital Jalandhar  OPD NO 2 Department of Panchakarma Dayanand Ayurvedic College and Hospital, Mahatma Hans Raj Marg Jalandhar Punjab India
Jalandhar
PUNJAB 
8054004479

kavitaguptamlt@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DAC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E669||Obesity, unspecified. Ayurveda Condition: MEDOROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-virecana-karma, विरेचन-कर्म (Procedure Reference: Charak Sutra 21, Procedure details: DAY 1-5 Deepana & pachana will be performed with trikatu churan 3 gm twice daily before food with lukewarm water till the appropriate symptoms of agni deepana is attained.snehpana increasing dose with Triphala ghrit will be done with proper oleation features will achieved .During the gap of 3 days & day of virechana sarvanga abhyanaga will be done followed by swedana. Virechana karama will be performed by the administration of trivritta avaleha dose mat vary as per the kostha & agni of patient. Samsarjana karma will be advised for 3 - 7 days depends upon the shudhi. Maximum duration for procedure will be 23 days.)
2Intervention ArmDrugClassical(1) Medicine Name: Trayushanadi Loha, Reference: Yog Ratankar Medoroga Chikitsa, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: Honey), Additional Information: -
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1.Subjects diagnoised as per mentioned criteria and willing for study
2.Subjects between 16 and 45 years irrespective to gender
3.Subjects having BMI 30-34.4 KG/M2
4.Postpartum more than 1 year
5.Fit for virechana Procedure 
 
ExclusionCriteria 
Details  1.Subjects not willing for study
2.Pregnant and lactating women will be excluded
3.Subjects having any other major complicated diseases like Diabetes Mellitus, Cardiac Diseases, Renal disorders, Thyroid disorders, HTN, Malignancy ,Drugs induced, PCOS AND PCOD 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Significant improvement in the clinical symptoms of obesity
1.Ati Kshudha
2.Ati Pipasa
3.Ati Sweda
4.Alasya
5.Kshudra Shwasa
6.Dourbalaya 
Day 0, 20th, 40th, 60th  
 
Secondary Outcome  
Outcome  TimePoints 
1.Body weight
2.Body mass index
3.Waist -hip ratio
4.Mid arm circumference
5.Chest Circumference
6.Abdominal Girth
7.Thigh Circumference 
Day 0 ,Day 20th ,Day 40th Day 60th 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   02/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The total of 60 patients will be selected who are between age group of 16 to 45 years of either sex who are diagnosed with Sthaulya on the basis of sign and symptoms. Patients will be divided into two groups (Trial Group A and Trial Group B). Group A will be intervene with Virechana along with Oral Administartion of  Trayushanandi Loha and Group B will be intervene with Oral medication Trayushanadi Loha and conduct a clinical study - To evaluate the efficacy of Tryaushanadi Loha  in the management of Sthaulya w.s.r to Obesity,To evaluate the efficacy of Virechana  along with  Oral Administration of Trayushanandi Loha  in the management of Sthaulya w.s.r to Obesity, To Compare  the difference of efficacy of Oral administration of Trayushanadi Loha  with and without Virechana in the management of Sthaulya w.s.r to Obesity. 
Close